These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36011036)

  • 1. Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy.
    Furumoto H; Okada R; Kato T; Wakiyama H; Inagaki F; Fukushima H; Okuyama S; Furusawa A; Choyke PL; Kobayashi H
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
    Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
    Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials.
    Okada R; Furusawa A; Vermeer DW; Inagaki F; Wakiyama H; Kato T; Nagaya T; Choyke PL; Spanos WC; Allen CT; Kobayashi H
    EBioMedicine; 2021 May; 67():103345. PubMed ID: 33933782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models.
    Kato T; Okada R; Furusawa A; Inagaki F; Wakiyama H; Furumoto H; Okuyama S; Fukushima H; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2021 Nov; 20(11):2262-2273. PubMed ID: 34518299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near infrared photoimmunotherapy with an anti-mesothelin antibody.
    Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H
    Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.
    Nakajima T; Sano K; Mitsunaga M; Choyke PL; Kobayashi H
    Cancer Res; 2012 Sep; 72(18):4622-8. PubMed ID: 22800710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.
    Nagaya T; Okuyama S; Ogata F; Maruoka Y; Knapp DW; Karagiannis SN; Fazekas-Singer J; Choyke PL; LeBlanc AK; Jensen-Jarolim E; Kobayashi H
    Oncotarget; 2018 Apr; 9(27):19026-19038. PubMed ID: 29721181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near infrared photoimmunotherapy of B-cell lymphoma.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
    Mol Oncol; 2016 Nov; 10(9):1404-1414. PubMed ID: 27511870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-Infrared Photoimmunotherapy of Cancer.
    Kobayashi H; Choyke PL
    Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.
    Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
    Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
    Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near-infrared photoimmunotherapy in the models of hepatocellular carcinomas using cetuximab-IR700.
    Takao S; Fukushima H; King AP; Kato T; Furusawa A; Okuyama S; Kano M; Choyke PL; Escorcia FE; Kobayashi H
    Cancer Sci; 2023 Dec; 114(12):4654-4663. PubMed ID: 37817415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
    Inagaki FF; Wakiyama H; Furusawa A; Okada R; Kato T; Fujimura D; Okuyama S; Fukushima H; Takao S; Choyke PL; Kobayashi H
    Biomed Pharmacother; 2023 Apr; 160():114390. PubMed ID: 36791566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
    Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
    Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.
    Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H
    Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic near-infrared photoimmunotherapy in an orthotopic head and neck cancer model.
    Okada R; Furusawa A; Inagaki F; Wakiyama H; Kato T; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
    Cancer Sci; 2021 Aug; 112(8):3041-3049. PubMed ID: 34101947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.